Pfam Domains GO Terms
| zf-C4 |
| Hormone recep |
| response to corticotropin-releasing hormone |
| cellular response to corticotropin-releasing hormone stimulus |
| endothelial cell chemotaxis |
| regulation of type B pancreatic cell proliferation |
| glucocorticoid receptor binding |
| cell migration involved in sprouting angiogenesis |
| blood vessel endothelial cell migration |
| cellular response to vascular endothelial growth factor stimulus |
| nuclear receptor activity |
| steroid hormone receptor activity |
| sprouting angiogenesis |
| endothelial cell migration |
| epithelial cell migration |
| epithelium migration |
| tissue migration |
| positive regulation of endothelial cell proliferation |
| fat cell differentiation |
| cellular response to fibroblast growth factor stimulus |
| response to fibroblast growth factor |
| steroid hormone mediated signaling pathway |
| regulation of endothelial cell proliferation |
| intracellular receptor signaling pathway |
| hormone-mediated signaling pathway |
| ameboidal-type cell migration |
| transcription initiation from RNA polymerase II promoter |
| cellular response to steroid hormone stimulus |
| positive regulation of epithelial cell proliferation |
| transcription factor complex |
| cell chemotaxis |
| DNA-templated transcription, initiation |
| nuclear membrane |
| cellular response to peptide hormone stimulus |
| RNA polymerase II regulatory region sequence-specific DNA binding |
| angiogenesis |
| cellular response to peptide |
| response to steroid hormone |
| regulation of epithelial cell proliferation |
| response to peptide hormone |
| blood vessel morphogenesis |
| sequence-specific DNA binding |
| DNA-binding transcription activator activity, RNA polymerase II-specific |
| response to peptide |
| transcription by RNA polymerase II |
| blood vessel development |
| protein heterodimerization activity |
| cellular response to growth factor stimulus |
| RNA polymerase II proximal promoter sequence-specific DNA binding |
| vasculature development |
| cardiovascular system development |
| cellular response to lipid |
| response to growth factor |
| cellular response to organic cyclic compound |
| chemotaxis |
| taxis |
| negative regulation of cell cycle |
| cellular response to organonitrogen compound |
| cellular response to hormone stimulus |
| transcription, DNA-templated |
| nucleic acid-templated transcription |
| RNA biosynthetic process |
| tube morphogenesis |
| cellular response to nitrogen compound |
| zinc ion binding |
| tube development |
| response to lipid |
| circulatory system development |
| anatomical structure formation involved in morphogenesis |
| response to hormone |
| positive regulation of cell population proliferation |
| response to organic cyclic compound |
| cell migration |
| response to organonitrogen compound |
| cellular response to oxygen-containing compound |
| cell motility |
| localization of cell |
| response to nitrogen compound |
| nucleobase-containing compound biosynthetic process |
| heterocycle biosynthetic process |
| aromatic compound biosynthetic process |
| regulation of cell cycle |
| positive regulation of transcription by RNA polymerase II |
| cellular response to endogenous stimulus |
| organic cyclic compound biosynthetic process |
| locomotion |
| DNA binding |
| response to endogenous stimulus |
| positive regulation of transcription, DNA-templated |
| movement of cell or subcellular component |
| response to oxygen-containing compound |
| DNA-binding transcription factor activity, RNA polymerase II-specific |
| regulation of cell population proliferation |
| cellular nitrogen compound biosynthetic process |
| positive regulation of nucleic acid-templated transcription |
| positive regulation of RNA biosynthetic process |
| RNA metabolic process |
| cellular macromolecule biosynthetic process |
| positive regulation of RNA metabolic process |
| macromolecule biosynthetic process |
| positive regulation of nucleobase-containing compound metabolic process |
| positive regulation of macromolecule biosynthetic process |
| positive regulation of cellular biosynthetic process |
| positive regulation of gene expression |
| gene expression |
| positive regulation of biosynthetic process |
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
| Screen | Score |
|---|---|
| Dimethyloxaloylglycine 100μM R05 exp229 | -2.01 |
| Pyridostatin 4μM R05 exp240 | -1.99 |
| LJH685 5μM R02 exp73 | -1.73 |
| 2-Methoxyestradiol 0.55μM R07 exp310 | 1.75 |
| Resveratrol 16μM R03 exp147 | 1.82 |
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 0/1 |
| 909776.0 | 0/1 |
| bile duct | 0/28 |
| blood | 0/28 |
| bone | 0/26 |
| breast | 0/33 |
| central nervous system | 0/56 |
| cervix | 0/4 |
| colorectal | 0/17 |
| esophagus | 0/13 |
| fibroblast | 0/1 |
| gastric | 0/16 |
| kidney | 0/21 |
| liver | 0/20 |
| lung | 0/75 |
| lymphocyte | 0/16 |
| ovary | 0/26 |
| pancreas | 0/24 |
| peripheral nervous system | 0/16 |
| plasma cell | 0/15 |
| prostate | 0/1 |
| skin | 0/24 |
| soft tissue | 0/9 |
| thyroid | 0/2 |
| upper aerodigestive | 0/22 |
| urinary tract | 0/29 |
| uterus | 0/5 |
Expression Distribution